Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

China · Delayed Price · Currency is CNY

14.85

-0.10 (-0.67%)

Aug 4, 2026, 3:00 PM CST

-33.44% (1Y)

Market Cap	2.96B -33.0%
Revenue (ttm)	625.30M -5.3%
Net Income	-11.56M
EPS	-0.06
Shares Out	198.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.27 (1.81%)
Ex-Dividend Date	Jun 6, 2025

Volume	1,703,900
Open	14.98
Previous Close	14.95
Day's Range	14.79 - 15.04
52-Week Range	12.62 - 23.04
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real es... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1909

Employees 1,119

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603896

Full Company Profile

Financial Performance

In 2025, SHA:603896's revenue was 640.18 million, a decrease of -9.21% compared to the previous year's 705.11 million. Earnings were 18.17 million, a decrease of -89.58%.

Financial Statements